Efficacy and safety of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms

17 May 2025 (16:20 - 16:30)
Organised by: Logo
Congress Presentation Part of: Late-breaking science in heart failure, cardiomyopathies, pulmonary hypertension and valvular heart disease Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)